Oscar Health (NYSE:OSCR) Director Sells 600,000 Shares

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 600,000 shares of the company’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00. Following the transaction, the director directly owned 480,866 shares of the company’s stock, valued at $14,589,474.44. This represents a 55.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The stock was sold at an average price of $30.79, for a total value of $4,618,500.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $748,592.80.

Oscar Health Stock Down 1.5%

Shares of NYSE OSCR traded down $0.47 during midday trading on Monday, reaching $30.00. The company’s stock had a trading volume of 3,638,656 shares, compared to its average volume of 7,137,195. The stock has a 50 day simple moving average of $30.27 and a 200-day simple moving average of $22.13. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $9.26 billion, a price-to-earnings ratio of 21.43, a PEG ratio of 0.63 and a beta of 2.36. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.55.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter in the prior year, the company posted ($0.89) earnings per share. The firm’s revenue was up 70.4% on a year-over-year basis. Equities research analysts predict that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Institutional Trading of Oscar Health

Several large investors have recently added to or reduced their stakes in OSCR. Thrive Capital Management LLC boosted its position in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. bought a new position in Oscar Health in the 1st quarter valued at $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Oscar Health by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after purchasing an additional 8,879 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after purchasing an additional 132,149 shares during the period. Institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on OSCR shares. Wolfe Research started coverage on Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Barclays increased their price target on Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Piper Sandler restated an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Finally, Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Oscar Health has an average rating of “Hold” and a consensus price target of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.